Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine（NIH）

N/A

Report date: 2023/01/16 20:00:27

Base Information

Drug NameEpstein-Barr Virus (EBV) Glycoprotein 350 Vaccine（NIH）
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfectious MononucleosisEpstein-Barr Virus InfectionsHerpesviridae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsInfectious MononucleosisEpstein-Barr Virus InfectionsHerpesviridae Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A